High-throughput miniaturized immunoassay for human interleukin-13 secreted from NK3.3 cells using homogenous time-resolved fluorescence

被引:7
作者
Enomoto, K
Araki, A
Nakajima, T
Ohta, H
Dohi, K
Préaudat, M
Seguin, P
Mathis, G
Suzuki, R
Kominami, G
Takemoto, H
机构
[1] Shionogi & Co Ltd, Res Dev Labs, Toyonaka, Osaka 5610825, Japan
[2] Shionogi & Co Ltd, Discovery Res Labs, Fukushima Ku, Osaka 5530002, Japan
[3] Shionogi & Co Ltd, Diagnost Dept, Settsu, Osaka 5660022, Japan
[4] CIS Bio Int, F-30203 Bagnols Sur Ceze, France
[5] Shionogi Inst Med Sci, Settsu, Osaka 5660022, Japan
关键词
rare earth cryptates; homogeneous time-resolved fluorescence; immunoassay; high-throughput screening; interleukin-2; interleukin-13; natural killer cell;
D O I
10.1016/S0731-7085(01)00596-9
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A miniaturized immunoassay for human interleukin-13 (IL-13) using homogeneous time-resolved fluorescence (HTRF(R)) has been developed. In this assay, IL-13 which was secreted from NK3.3 cells stimulated with interleukin-2 (IL-2) was detected by measuring the time-resolved fluorescence after adding a mixture of three reagents, biotinylated anti-IL-13 monoclonal antibody, europium cryptate (fluorescence donor)-labeled different anti-IL-13 monoclonal antibody and crosslinked allophycocyanin (fluorescence acceptor)-conjugated with streptavidin in a 384-well assay plate. The detection limit of IL-13 using this immunoassay was estimated to be less than 600 pg/ml and IL-13 levels measured by this method were very close to those measured by enzyme linked immunosorbent assay (ELISA; the correlation coefficient was 0.9535). The proposed assay requires only a fourth of the quantities of all reagents compared with the assay using a conventional 96-well microtiter plate. Furthermore, there is no need to transfer the culture supernatant to another assay plate and wash the plate. Therefore, this miniaturized immunoassay is economical and efficient and is particularly suitable for high-throughput drug screening. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:73 / 79
页数:7
相关论文
共 15 条
[1]   High throughput screening for human interferon-γ production inhibitor using homogenous time-resolved fluorescence [J].
Enomoto, K ;
Aono, Y ;
Mitsugi, T ;
Takahashi, K ;
Suzuki, R ;
Préaudat, M ;
Mathis, G ;
Kominami, G ;
Takemoto, H .
JOURNAL OF BIOMOLECULAR SCREENING, 2000, 5 (04) :263-268
[2]   Requirement for IL-13 independently of IL-4 in experimental asthma [J].
Grünig, G ;
Warnock, M ;
Wakil, AE ;
Venkayya, R ;
Brombacher, F ;
Rennick, DM ;
Sheppard, D ;
Mohrs, M ;
Donaldson, DD ;
Locksley, RM ;
Corry, DB .
SCIENCE, 1998, 282 (5397) :2261-2263
[3]  
HAYAKAWA K, 1991, J IMMUNOL, V146, P2453
[4]  
Hoshino T, 1999, J IMMUNOL, V162, P5070
[5]   Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence [J].
Kolb, AJ ;
Kaplita, PV ;
Hayes, DJ ;
Park, YW ;
Pernell, C ;
Major, JS ;
Mathis, G .
DRUG DISCOVERY TODAY, 1998, 3 (07) :333-342
[6]  
Kolb J.M., 1996, J BIOMOL NMR, V1, P203
[7]  
KORNBLUTH J, 1982, J IMMUNOL, V129, P2831
[8]   DIFFERENTIAL REGULATION OF IL-13 AND IL-4 PRODUCTION BY HUMAN CD8(+) AND CD4(+) T(H)0, T(H)1 AND T(H)2 T-CELL CLONES AND EBV-TRANSFORMED B-CELLS [J].
MALEFYT, RD ;
ABRAMS, JS ;
ZURAWSKI, SM ;
LECRON, JC ;
MOHANPETERSON, S ;
SANJANWALA, B ;
BENNETT, B ;
SILVER, J ;
DEVRIES, JE ;
YSSEL, H .
INTERNATIONAL IMMUNOLOGY, 1995, 7 (09) :1405-1416
[9]  
Mathis G, 1997, ANTICANCER RES, V17, P3011
[10]  
MATHIS G, 1995, CLIN CHEM, V41, P1391